EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:EnGeneIC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013944
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference molecules, chemotherapeutic agents, and molecularly targeted drugs into targeted tumor cells. EnGeneIC’s technologies include targeted drug delivery, EnGeneIC dream vector technology, targeted small interfering RNA delivery and targeted microRNA delivery. The company offers preclinical development and clinical trial services. It develops proprietary EDV nanocell platform for the delivery of chemotherapeutics and functional nucleic acids in cancer. The company operates in Lane Cove West, Australia and New York, the US. EnGeneIC is headquartered in Sydney, New South Wales, Australia.

EnGeneIC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EnGeneIC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EnGeneIC Ltd, Medical Devices Deals, 2011 to YTD 2017 9
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
EnGeneIC Raises USD10 Million in Series B Financing 11
EnGeneIC Raises USD7 Million Financing 12
EnGeneIC Raises USD1 Million Financing 13
Partnerships 14
EnGeneIC Enters into Agreement with Millennium Pharma 14
EnGeneIC Ltd – Key Competitors 15
EnGeneIC Ltd – Key Employees 16
EnGeneIC Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jan 25, 2016: EnGeneIC Strengthens Board of Directors to Support U.S. Expansion 18
Clinical Trials 19
Apr 07, 2016: EnGeneIC Announces Publication of Late-Stage Canine Brain Cancer Study Results in PLOS ONE 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Key Facts 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EnGeneIC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EnGeneIC Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
EnGeneIC Ltd, Medical Devices Deals, 2011 to YTD 2017 9
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
EnGeneIC Raises USD10 Million in Series B Financing 11
EnGeneIC Raises USD7 Million Financing 12
EnGeneIC Raises USD1 Million Financing 13
EnGeneIC Enters into Agreement with Millennium Pharma 14
EnGeneIC Ltd, Key Competitors 15
EnGeneIC Ltd, Key Employees 16

★海外企業調査レポート[EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The National Petrochemical Co:企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Universal Music Group:企業の戦略的SWOT分析
    Universal Music Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • U.S. Neurosurgical Inc (USNU):企業の財務・戦略的SWOT分析
    Summary U.S. NeuroSurgical Inc (USN) is a medical service company that provides biotechnology and neurosurgery services. The company assists and facilitates medical device manufacturers in gaining access and entry into the US neurosurgical marketplace. It provides treatment services such as gamma kn …
  • Ariel Corp:企業の戦略的SWOT分析
    Ariel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Delfasco, LLC:企業の戦略・SWOT・財務情報
    Delfasco, LLC - Strategy, SWOT and Corporate Finance Report Summary Delfasco, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • Cutera Inc (CUTR):企業の製品パイプライン分析2018
    Summary Cutera Inc (Cutera) is a medical device company that manufactures, designs, markets, and services medical and aesthetic devices. The company provides laser and energy based aesthetics systems such as pico technology, excel HR technology, excel V technology, Juliet technology, secret RF techn …
  • Lagardere Travel Retail S.A.S:企業の戦略・SWOT・財務情報
    Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report Summary Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CryoLife Inc (CRY):企業の製品パイプライン分析2018
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • Hertz Global Holdings Inc:企業のM&A・事業提携・投資動向
    Hertz Global Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hertz Global Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Network Rail Limited:企業の戦略・SWOT・財務情報
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BOC Hong Kong (Holdings) Ltd:戦略・SWOT・企業財務分析
    BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bandera Electric Cooperative Inc:企業の戦略的SWOT分析
    Bandera Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Muscatine Power and Water:企業の戦略的SWOT分析
    Muscatine Power and Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nitori Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • NeuroMetrix Inc (NURO):企業の財務・戦略的SWOT分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, quell health cloud, DPNCheck point-of- …
  • Sunoco LP (SUN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunoco LP (Sunoco), a master limited partnership company that sells motor fuels in retail and wholesale channels. It offers motor fuel under brands such as Sunoco, Citgo, Chevron, Conoco, Aloha, Exxon, Mahalo, Mobil, Phillips 66, Texaco, Shell, Shamrock and Valero. The company operates throu …
  • SunTrust Banks, Inc.:戦略・SWOT・企業財務分析
    SunTrust Banks, Inc. - Strategy, SWOT and Corporate Finance Report Summary SunTrust Banks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆